A prospective, randomized study was performed to detail clinical experience with both patient-controlled epidural analgesia (PCEA) and midwife-administered intermittent bolus (I B) epidural analgesia during labour, under the conditions pertaining in a busy obstetric delivery unit. Both methods used 0.125% bupivacaine plus fen tanyl, and similar rescue supplementation, although management decisions related to epidural analgesia were made principally by attending midwives.
Patient-controlled epidural analgesia (PCEA) during labour may offer advantages over intermittent bolus and infusion techniques J -5 • Two reviewers have recently supported the contention that it is both safe and likely to continue as a valuable option for women in labou~·7. Nevertheless, staff-administered intermittent boluses (IB) are the most commonly used method of epidural pain relief in labour in our hospital and probably in Australasia.
Information regarding the use of PC EA during labour is limited to that from the specific and highly regulated conditions of controlled trials. Results obtained under such conditions may not accurately reflect those observed during routine obstetric delivery ward management.
We detailed clinical experience with PCEA in a prospective series, assessed concurrently with that of women who had midwife-administered intermittent boluses.
MATERIALS AND METHODS
In order to reduce selection bias, participating women were randomized (stratified for parity) to epidural management by either IB or PCEA. Prior to the evaluation and recruitment, Institutional Research and Ethics Committee approval and written, informed consent were obtained. The women evaluated were of mixed parity, had singleton cephalic term pregnancy and were in established labour. Those delivering within two hours of initiating the epidural were excluded, since this time frame was considered necessary to allow adequate evaluation following the initial bolus. Participant information included a brief description of the two epidural methods and the type of data to be collected. Further detail with respect to epidural management, including, if applicable, detailed description of the PCA pump (Ivac PCA infusor, Phoenix, Aust.) and its optimum use, was given after good analgesia had been established.
Epidural analgesia was established in the usual manner for our unit, using a 10 ml bolus of 0.125070 bupivacaine with fentanyl 50 j1.g via a lumbar catheter, supplemented if necessary after 20 minutes with 4 ml 0.5% bupivacaine. Prescribed regimens for both methods under evaluation provided similar epidural solution, supplements and rate of supplementation, IB method consisted of repeated boluses identical to the initial solution hourly p.r.n., while PCEA was with 0.125070 bupivacaine with fentanyl 3 JLg/ml, 4 ml demand dose and 10 minute lockout. Unsatisfactory analgesia was corrected at the midwives' discretion by injection of 0.5% bupivacaine 4 ml, given no more frequently than hourly p.r.n. Maternal and fetal monitoring followed hospital protocol (hourly maternal respiratory rate and conscious state, blood pressure at 30-minute intervals and 5-minute intervals for 20 minutes after any staff-administered bolus; and continuous fetal heart rate monitoring). Observations included demographies, 30-minute then hourly visual analog pain score (VAS), maximum VAS over the previous hour and motor block (modified Bromage scale i.e. 0 = bilateral sustained straight leg raise, 1 = unable to straight leg raise, 2 = just able to flex knees, 3 = foot movement only). The upper level of sensory block was assessed two hourly by loss of sensation to ice. Vomiting, shivering, need for urinary catheterization and hypotension (a fall of 30% or systolic blood pressure less than 90 mmHg) were noted. Delivery and PCEA details were recorded and, at a 24 hour postpartum interview by an anaesthetist, women were asked to grade the quality of their analgesia and their level of satisfaction with the epidural method.
All intra-partum data collection was performed by the attending midwives, who also managed the epidural. Pain scores were collected for 12 hours or until spontaneous delivery or an obstetric decision to assist delivery. Data described with median and interquartile range were analysed by Wilcoxon Rank Sum test and frequency data using Fisher's Exact test or the Cochran-Mantel-Haenszel Chi-square test as appropriate, at a 5% level of significance.
RESULTS
Of 198 women evaluated, 31 were excluded due to delivery within two hours and three due to inadequate data collection, leaving 167 cases, of whom 82 received PC EA and 85 lB. These women were similar for age, weight, parity, gestation, cervical dilatation, insurance category and type of labour (Table 1) .
Median hourly pain scores were not signficantly different ( Figure I ), but maximum scores were significantly higher at two and three hours in those receiving IB, this trend continuing to five hours ( Figure 2 ). Women's ratings of pain relief and satisfaction were similar for both methods ( Table 2 ). Motor block scores were low with both methods (median 0, interquartile range 0-1 for assessments between two and eight hours post-epidural), with 74% of all scores assessed up to eight hours being zero. At some time during epidural analgesia, 25% of all women were weight-bearing (representing 81 % of those who attempted to do so). Median upper sensory levels (T8-T9) were similar for both methods at all times, as were epidural side-effects (Table 3) with the exception of urinary catheterization, which was significantly more common in those using PCEA (relative risk 1.37, 95% Cl 1.07-1.77). There was no difference with respect to the duration of the epidural, but women using PC EA had a significantly longer second stage of labour and higher risk of instrumental delivery (relative risk versus IB 1.57, Cl 1.03-2.38). Neonatal Apgar scores were similar. There was a significantly higher number of supplements and rate of bupivacaine usage in those using PCEA, although the latter did not hold if delivery was by caesarean section (Table 4 ). Median (interquartile range) for demands per hour with PCEA was 2.6 (1.5-4.3) and for the ratio of successful demands to demands made 0.6 (0.4-0.8).
DISCUSSION
Information obtained in this prospective series reflects our clinical experience with two methods of epidural analgesia as they are managed, predominantly by midwives, under routine conditions in a busy obstetric unit. Our obstetric population is mainly "high-risk", and the rate of epidural analgesia III Although cautious interpretation of differences detected amongst women using IB or PCEA is necessary because this was not a controlled comparison, those women receiving a patient-controlled analgesia (PCA) approach appeared to achieve more consistent analgesia, although they had a longer second stage of labour and an increased rate of instrumental delivery.
Pain Relief and Satisfaction
Low median pain scores during labour in this series, irrespective of epidural method, confirm the efficacy of the low-dose bupivacaine-opioid mixtures we routinely employ. The clinical significance of the observed differences in scores between those receiving PCEA and IB is, arguably, unimportant. Controlled trials of PCEA and IB using identical solutions also report statistically significant, but clinically small, reductions in pain score with the former". The proffered explanation is immediate access to more solution and less likelihood of a marked waning of effect as may occur between staff-prepared and staffadministered boluses. Alternative explanations for our findings include denser sensory block secondary to greater doses of bupivacaine used in association with PCEA, or a greater reluctance of our midwives to supplement their own "top-ups" compared with women's self-administered boluses.
This series confirmed our impression that women's ratings and satisfaction with epidural analgesia were high, and indicated that both epidural methods had good consumer acceptability. A controlled study, preferably of double-blind and cross-over design, would be necessary to obtain an accurate assessment of consumer preferences for either of the two methods.
Supplementation and Bupivacaine Use
Women using PCEA in this series had a significantly higher rate of supplementation than those on IB, this rate being higher than that reported in controlled trials using similar PCEA solution and variables 9 ,ll. It may have been that the women were not using the PCA pump optimally, either due to inadequate information, encouragement and instruction, or poor motivation despite voluntary entry to the study. Alternatively, as our unit does not set specific criteria for when analgesia should be supplemented, our midwives may have intervened more readily than during controlled trial conditions. In the latter, PCEA would be expected to be used optimally and participants' pain relief and satisfaction may be influenced by the presence of an attentive researcher or staff member who is keen to reinstruct and encourage.
Clinical trials consistently indicate that PCEA minimizes drug use compared with other methods"lo,ll,l2l'. The rates of bupivacaine use in this series were low with both methods. The small differences detected were not clinically important with respect to the degree of motor block associated with analgesia or the risk of local anaesthetic toxicity, only having potential impact in the rare situation of inadvertent subarachnoid administration of solution. We found that despite lower hourly drug usage with our initial regimen prescribed for PCEA compared with IB, a higher supplementation rate with PCEA lead to an overall increase in bupivacaine use of about 15070. This effect was not evident in women who proceeded to caesarean section, possibly because extra supplementary boluses were most frequently required in late labour and were thus preceded by the obstetric decision to intervene.
Obstetric Outcome
We were surprised to find that our PC EA and IB series were associated with different obstetric outcomes. Women using PC EA had a significantly longer second stage of labour (almost twice the median duration), predominantly due to a greater duration in those who delivered spontaneously. Although the caesarean section rate was not different, those having PCEA appeared significantly more likely to need instrumental delivery compared with a similar number of women having IB epidural analgesia. Despite an apparently similar obstetric population evaluated in the series, it is possible that this was due to unknown covariates, undetected demographic differences between the groups having each method, or a chance finding. Considering the shorter second stage and higher pain scores however, a more likely reason is that those having the IB method were more likely to have epidural solution withheld in late labour. Despite the policy of the Anaesthetic Department to continue analgesia throughout labour, some of our midwives and obstetricians pursue such an approach in an attempt to minimize the effects of epidural block on expulsive urge and powers in the second stage. Women using PCEA were free to continue to administer solution throughout this period, and may also have had more profound block at this time due to the higher supplementation rate with small volumes of concentrated soution. Chestnut suggested in 1991 that no published study had been able consistently to provide high quality second stage analgesia without increasing the instrumental delivery rate 6 • That very low instrumental delivery rates can be achieved with PCEA throughout labour has been demonstrated l " and this series highlights the need for us to improve our management of epidural analgesia, especially PCEA techniques, and to evaluate all methods with respect to their efficacy for perineal pain and effect on delivery.
Neonatal outcome was only assessed by Agpar scoring, and proved to be consistent with clinical experience in our entire, principally high-risk, obstetric population.
Epidural Side-Effects
A controlled trial of PCEA and IBl has reported similar cephalad sensory levels during use in labour and our findings were in agreement. PC EA and IB methods appeared to produce similar degrees of lower limb weakness, this usually being undetectable. The majority of women using epidural analgesia who wished to weight-bear were able to do so. Both epidural methods resulted in a similar frequency of adverse events which potentially may have been influenced by an epidural, the exception being temporary urinary catheterization to empty the bladder. This was a common requirement during epidural analgesia, and it would have been of interest had a group using non-epidural methods of analgesia been evaluated concurrently. A statistically higher incidence in those having PCEA may possibly be explained by their greater requirement for bupivacaine of high concentration. Hypotension occurred in less than 10070 of women in this series and was almost always associated with the initial bolus of epidural solution. We do not routinely give a fixed volume of intravenous crystalloid solution prior to the epidural and use ephedrine early in management.
CONCLUSION
Our experience with PCEA supports evidence from clinical trials that the quality of pain relief and maternal satisfaction which can be achieved are at least comparable to a staff-administered IB method. It also indicates that midwifery management (with minimal anaesthetic supervision) of PCEA, which is used in only a small proportion of epidurals during labour in our unit, may give rise to potential problems; for example, increased supplementation, bladder instrumentation and assisted vaginal delivery. Whether the latter were causally related to the method itself or rather reflected different attitudes and management practices by midwives and obstetricians in our delivery suite requires further evaluation. It is suggested that before introducing different methods of epidural analgesia into routine practice, a multidisciplinary review of relevant obstetric and epidural management be undertaken and continuous audit of outcome variables be instituted.
